COVID-19-associated acute kidney injury: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 15: | Line 15: | ||
==[[COVID-19-associated acute kidney injury causes|Causes]]== | ==[[COVID-19-associated acute kidney injury causes|Causes]]== | ||
==[[COVID-19-associated acute kidney injury differential diagnosis|Differentiating | ==[[COVID-19-associated acute kidney injury differential diagnosis|Differentiating COVID-19-Associated Acute Kidney Injury From Other Diseases]]== | ||
==[[COVID-19-associated acute kidney injury epidemiology and demographics|Epidemiology and Demographics]]== | ==[[COVID-19-associated acute kidney injury epidemiology and demographics|Epidemiology and Demographics]]== | ||
Revision as of 22:14, 24 June 2020
Template:COVID-19-associated acute kidney injury
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2], Nasrin Nikravangolsefid, MD-MPH [3]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating COVID-19-Associated Acute Kidney Injury From Other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies